rxstat › Drug prices › Calcipotriol

Calcipotriol (Dovonex) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Calcipotriol 50 mcg/g ointment costs about $0.89 to $1.25 per g on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Calcipotriol has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKONNBNS
50 mcg/g Ointmentper g$0.89$1.12$1.25$1.15$1.12
Plan coverageCoveredCoveredCoveredCoveredSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Dovonex 50 mcg/g Ointment · LEO
    DIN 01976133 · $0.89/g · Covered
Saskatchewan: 1 product
  • Dovonex 50 mcg/g Ointment · LEO
    DIN 01976133 · $1.12/g · Covered
Ontario: 1 product
  • Dovonex 50 mcg/g Ointment · Leo Pharma Inc.
    DIN 01976133 · $1.25/g · Covered
New Brunswick: 1 product
  • Dovonex 50 mcg/g Ointment · LEO
    DIN 01976133 · $1.15/g · Covered
Nova Scotia: 1 product
  • Dovonex 50 mcg/g Ointment · LEO
    DIN 01976133 · $1.12/g · Special approval

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 2
Reports on file
2

Reports by product

The DIN is printed on your prescription label.

Resolved
DOVONEX
50MCG · OINTMENT · LEO PHARMA INC
DIN 01976133 · ended Nov 1, 2022 · Delay in shipping of the drug.
Discontinued
DOVONEX - CRM 50MCG/GM
50MCG · CREAM · LEO PHARMA INC
DIN 02150956

What's happening

There are no active shortage reports for Calcipotriol. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Calcipotriol is classified under “ANTIPSORIATICS FOR TOPICAL USE” (ATC D05AX).

Recent changes

Common questions

How much does Calcipotriol cost in Canada?

Calcipotriol 50 mcg/g ointment costs about $0.89 to $1.25 per g on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Is Calcipotriol covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: covered; Ontario: covered; New Brunswick: covered; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Calcipotriol be back in stock in Canada?

Calcipotriol has no active shortage; supply is normal per Health Canada reports.

Why is Calcipotriol in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antipsoriatics for topical use)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.